Embecta Corp. engages in the provision of medical devices used in the treatment of diabetes. Its products include pen needles, syringes, and safety devices complemented by a digital application. The company was founded in 1924 and is headquartered in Parsippany, NJ.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
2,100
Frequently Asked Questions
What is Market Cap of Embecta Corp?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Embecta Corp market cap is $838.09M.
What is the 52-week high for Embecta Corp?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Embecta Corp 52 week high is $21.48 as of October 25, 2025.
What is the 52-week low for Embecta Corp?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Embecta Corp 52 week low is $9.20 as of October 25, 2025.
What is the PE ratio of Embecta Corp?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Embecta Corp’s P/E ratio is 10.02.
What is the Price-to-Book ratio of Embecta Corp?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Embecta Corp P/B ratio is -1.2514.
What is the 50-day moving average of Embecta Corp?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Embecta Corp 50-day moving average is $14.28.
